PAI-1–regulated extracellular proteolysis governs senescence and survival in Klotho mice
Open accessThe DOI matches its Crossref record; 46 of the 48 references it cites were found in a registry or an index.
Abstract
Significance: Plasminogen activator inhibitor-1 (PAI-1) is an essential mediator of cellular senescence in vitro and is one of the biochemical fingerprints of senescence in vivo. Klotho -deficient ( kl/kl ) mice display a complex phenotype reminiscent of human aging and exhibit age-dependent increases in PAI-1 in tissues and in plasma. Thus, we hypothesized that PAI-1 contributes to the aging-like phenotype of kl/kl mice. We observed that either genetic deficiency or pharmacological inhibition of PAI-1 in kl/kl mice was associated with reduced evidence of senescence, preserved organ structure and function, and a fourfold increase in median lifespan. These findings indicate that PAI-1 is a critical mediator of senescence in vivo and defines a novel target for the prevention and treatment of age-related disorders in man.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“SASP not only includes proinflammatory molecules but also enzymes involved in ECM remodelling, such as matrix metalloproteinases (MMPs)77, serine/cysteine proteinase inhibitors (SERPINs)78 and tissue inhibitors of metalloproteinases (TIMPs)79”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [78]
In the citing paper
“Furthermore, PAI-1 knockdown extends lifespan and healthspan in Klotho-deficient mice, which have an accelerated aging-like phenotype (77).”
From Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity (2015) · cites this paper as [77]
In the citing paper
“In another example, PAI-1 inhibitors reduced senescent cell abundance in Klotho-deficient mice (77).”
From Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity (2015) · cites this paper as [77]
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 1×
“In addition to this pattern of protein production and secretion, senescent cells display a distinctive morphology, and can be identified by increased expression of senescence-associated β-galactosidase (7).”
BackgroundOncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“Senescence can be triggered by a number of factors, including DNA damage (9), oncogene induction (10), and oxidative stress (11).”
BackgroundThe senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206 · cited 1×
“Cellular senescence, which halts the proliferative capacity of cells, is associated with the manifestation of the senescenceassociated secretory phenotype (3) and the production and secretion of a distinct set of proteins (2, 4), including insulin-like growth factor-binding proteins (IGFBPs), interleukins (ILs), trans…”
BackgroundCellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441 · cited 2×
“A age contributes to the development of frailty and disease in humans, but the fundamental mechanisms that drive physiological aging are incompletely understood (1, 2).”
BackgroundMutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837 · cited 5×
“Mouse Behavioral Phenotyping Core Laboratory as described previously (13).”
BackgroundMethodInfluentialClearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 4×
“The results presented here indicate that PAI-1 is a critical contributor to, and not merely a marker of, senescence in vivo (12), and that novel therapies targeting PAI-1 or other components of the SMS (40) may prevent senescence and age-related pathologic changes in humans, including arteriosclerosis and emphysema.”
BackgroundInfluentialTelomere measurement by quantitative PCR
Cawthon, R. M. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.10.e47 · Cited by 3,487 · cited 1×
“Genomic DNA isolated from various tissues was used to measure telomere length by qRT-PCR as previously described with minor modification (46, 47).”
MethodFour faces of cellular senescence
Rodier, F., & Campisi, J. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201009094 · Cited by 2,070 · cited 1×
“A age contributes to the development of frailty and disease in humans, but the fundamental mechanisms that drive physiological aging are incompletely understood (1, 2).”
BackgroundSuppression of Aging in Mice by the Hormone Klotho
Kurosu, H., Yamamoto, M., Clark, J. D., Pastor, J. V., Nandi, A., Gurnani, P., McGuinness, O. P., Chikuda, H., Yamaguchi, M., Kawaguchi, H., et al. (2005) · Science · doi:10.1126/science.1112766 · Cited by 1,935 · cited 3×
“Klotho functions as an aging-suppressor protein by impeding the development of senescence in vitro and in vivo through inhibition of the Wnt (15), TGF-β (16), and IGF1 signaling pathways (17).”
BackgroundKrtolica, A., Parrinello, S., Lockett, S., Desprez, P.-Y., & Campisi, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211053698 · Cited by 1,730 · cited 2×
“Cellular senescence, which halts the proliferative capacity of cells, is associated with the manifestation of the senescenceassociated secretory phenotype (3) and the production and secretion of a distinct set of proteins (2, 4), including insulin-like growth factor-binding proteins (IGFBPs), interleukins (ILs), trans…”
Background
Cited by
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
Di Micco, R., Krizhanovsky, V., Baker, D., & d’Adda di Fagagna, F. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00314-w · Cited by 2,277
Senescent cells: an emerging target for diseases of ageing
Childs, B. G., Gluscevic, M., Baker, D. J., Laberge, R.-M., Marquess, D., Dananberg, J., & van Deursen, J. M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.116 · Cited by 1,284
Molecular and physiological manifestations and measurement of aging in humans
Khan, S. S., Singer, B. D., & Vaughan, D. E. (2017) · Aging Cell · doi:10.1111/acel.12601 · Cited by 530
“…systemic factors (e.g., GDF-11, CCL11, Klotho, b2 microglobulin); however, emerging evidence questions the role GDF-11 plays in aging mice (Conboy et al., 2005; Villeda et al., 2011; Eren et al., 2014; Laviano, 2014; Sinha et al., 2014; Brun & Rudnicki, 2015; Smith et al., ª 2017 The Authors.”
BackgroundSelf-citationCardoso, A. L., Fernandes, A., Aguilar-Pimentel, J. A., de Angelis, M. H., Guedes, J. R., Brito, M. A., Ortolano, S., Pani, G., Athanasopoulou, S., Gonos, E. S., et al. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.07.004 · Cited by 475
Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity
Palmer, A. K., Tchkonia, T., LeBrasseur, N. K., Chini, E. N., Xu, M., & Kirkland, J. L. (2015) · Diabetes · doi:10.2337/db14-1820 · Cited by 423
“In another example, PAI-1 inhibitors reduced senescent cell abundance in Klotho-deficient mice (77).”
Background
Metadata
- Authors
- Eren, M., Boe, A. E., Murphy, S. B., Place, A. T., Nagpal, V., Morales-Nebreda, L., Urich, D., Quaggin, S. E., Budinger, G. R. S., Mutlu, G. M., Miyata, T., & Vaughan, D. E.
- Affiliations
- Department of Medicine and
- Northwestern University (US)
- United Centers for Advanced Research and Translational Medicine, Tohoku University (JP)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2014-04-28
- Volume
- 111
- Issue
- 19
- Pages
- 7090-7095
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC4024885
- OpenAlex
- W2085742383
- Cited by
- 176
- References
- 48
- Citations by year
- 2026: 9 · 2025: 18 · 2024: 8 · 2023: 15 · 2022: 14 · 2021: 10 · 2020: 21 · 2019: 14 · 2018: 12 · 2017: 15 · 2016: 22 · 2015: 12 · 2014: 5
- FWCI
- 12.00
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs (I01 BX000201)
- National Institutes of Health (1p01hl108795-01)
- U.S. Public Health Service (T32 KD007169)
- National Heart, Lung, and Blood Institute (P01-HL-108795, 1P01 HL108795, R01HL051387)
- National Institute of Diabetes and Digestive and Kidney Diseases (T32DK007169)
- National Institute of Environmental Health Sciences (R01ES013995)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Keywords
- plasminogen activator inhibitor-1, Klotho, cellular senescence, extracellular proteolysis, serine protease inhibitors, aging, lifespan, tissue regeneration, arteriosclerosis, emphysema
- MeSH terms
- Fibroblast Growth Factor-23, Klotho Proteins, Aging, Animals, Extracellular Space, Female, Glucuronidase, Hemorrhagic Disorders, Longevity, Male, Mice, Inbred C3H, Mice, Inbred C57BL, Phenotype, Telomere, Cellular Senescence, Plasminogen Activator Inhibitor 1, Mice, Knockout, Cyclin-Dependent Kinase Inhibitor p16, Mice, Serpin E2, Proteolysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: PAI-1–regulated extracellular proteolysis governs senescence and survival in Klotho mice. https://app.cochat.ai/papers/10.1073/pnas.1321942111
- The paper
- Eren, M., Boe, A. E., Murphy, S. B., Place, A. T., Nagpal, V., Morales-Nebreda, L., Urich, D., Quaggin, S. E., Budinger, G. R. S., Mutlu, G. M., Miyata, T., & Vaughan, D. E. (2014). PAI-1–regulated extracellular proteolysis governs senescence and survival in Klotho mice. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1321942111
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.